Fj. Rubio et al., Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain, MOL CELL NE, 16(1), 2000, pp. 1-13
Human neural stem cells (HNSCs) may serve as a cellular vehicle for molecul
ar therapies as well as for cell replacement in the human CNS. The survival
, integration, and differentiation of HNSC.100, a multipotent cell line of
HNSCs (A. Villa et al. (2000), Exp. Neurol. 161, 67-84), conditionally perp
etuated by genetic and epigenetic means, was investigated after transplanta
tion to the striatum and substantia nigra of the adult, intact rat brain. T
hese are two key regions in the mammalian brain involved in the control of
voluntary movement and motor coordination, among other functions. Soon afte
r transplantation (1 week), the cells had already integrated in a nondisrup
tive manner into the surrounding tissue and migrated out of the implantatio
n site to different distances depending on graft location (in the range of
0.5-2.5 mm). Cell migration was markedly more extensive in the striatum, wh
ere the cells colonized the whole extent of the caudate-putamen, than in th
e substantia nigra region. The engrafted cells completely downregulated the
stem cell marker nestin and, due to their multipotential nature, different
iated and expressed mature neural markers. As expected from cells grafted i
nto nonneurogenic regions of the intact brain, the majority of differentiat
ed cells expressed GFAP (astroglia), but expression of other markers, like
GalC (oligodendroglia) and MAP2, beta-tubulin III, NeuN, and NSE (for matur
e neurons) could also be detected. These results demonstrate that genetical
ly perpetuated HNSCs, once transplanted, find residence in the host brain,
where they differentiate, generating mature neural cells in the host, chime
ric, adult mammalian brain. HNSCs cell lines may be a highly useful model f
or the development of humanized systems for cell replacement and/or gene tr
ansfer to the CNS, which will likely be strong candidates for future therap
eutic application in human neurodegenerative conditions.